Quality Issues Star In US FDA Complete Response Letter Trio

 
• By Bridget Silverman
  
drug manufacturing
Three FDA CRLs disclosed this week included manufacturing problems. • Source: Shutterstock

More from Complete Response Letters

More from Product Reviews